Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tolloid-like 1 pseudogene (ENSG00000274551) is a genomic sequence similar to the tolloid-like 1 (TLL1) gene, but contains mutations that prevent it from coding for a functional protein[2][4]. Pseudogenes like this often arise from duplication or retrotransposition events and accumulate mutations over time, leading to non-functionality at the protein level[2][4]. This pseudogene does not perform the enzymatic or developmental roles attributed to its protein-coding counterpart (TLL1), which is an astacin-like metalloprotease involved in heart development[5]. The pseudogene has no established role as a therapeutic target, biomarker, or in mediating drug action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tolloid-like 1 pseudogene.